The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Sionna Therapeutics Inc shares valued at $20,250,000 were purchased by TPG GP A, LLC on Feb 10 ’25. At $18.00 per share, TPG GP A, LLC acquired 1,125,000 shares. The insider’s holdings grew to 6,684,962 shares worth approximately $74.0 million following the completion of this transaction.
Also, RA CAPITAL MANAGEMENT, L.P. purchased 1,125,000 shares, netting a total of over 20,250,000 in proceeds. Following the buying of shares at $18.00 each, the insider now holds 6,923,365 shares.
Before that, ORBIMED ADVISORS LLC had added 550,000 shares to its account. In a trade valued at $9,900,000, the Director bought Sionna Therapeutics Inc shares for $18.00 each. Upon closing the transaction, the insider’s holdings increased to 550,000 shares, worth approximately $41.01 million.
As published in their initiating research note from TD Cowen on March 04, 2025, Sionna Therapeutics Inc [SION] has been a Buy. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of March 04, 2025, Guggenheim has initiated its “Buy” rating for SION.
Analyzing SION Stock Performance
During the last five days, there has been a surge of approximately 44.52%. Over the course of the year, Sionna Therapeutics Inc shares have dropped approximately -55.72%.
Support And Resistance Levels for Sionna Therapeutics Inc (SION)
According to the 24-hour chart, there is a support level at 9.80, which, if violated, would cause prices to drop to 8.54. In the upper region, resistance lies at 11.92. The next price resistance is at 12.78. RSI (Relative Strength Index) is 45.27 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.44, which suggests the price will decrease in the coming days. Percent R is at 35.06%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
